Training in the genetic basis of pediatric gastrointestinal disorders: The revolutions in genetics and genomics have led to discoveries in a range of GI diseases, many of which affect the health of children. Pediatricgastroenterologistswhoaretrainedingeneticresearchwillbeessentialintheefforttoidentifynovel genetic causes of GI disease, reveal their molecular mechanisms, and translate them into therapy. The outstanding laboratory, translational, and clinical research at CHOP and the Perelman School of Medicine (PSOM)presentanidealenvironmentforresearchcareerdevelopmentinthegeneticsofpediatricGIdisease. Theoverarchinggoalsofthistrainingprogramareto: ?TrainacadreofcommittedresearcherstoinvestigatethegeneticbasisofpediatricGIdiseaseandtouse thisknowledgetoimprovethehealthofchildrenandadults. ?Providetheseindividualswiththeskillsetsandfoundationforcareeradvancement. ?EncourageinnovationandleadershipinacademicpediatricGI.
The SpecificAims ofthistrainingprogramareto: ?Identify, recruit and foster the career development of post-doctoral research trainees from the pool of CHOPGIfellows,PSOMGIfellows,andotherscientistscommittedtotrainingandcareerdevelopmentin thegeneticsofpediatricgastrointestinaldisease. ?Matchtraineestrengthsandinterestswithmentoringteams. ?Provideintensivementoredresearchexperienceandtrainingwithdedicatedfaculty. ?Providecareermentoring,includingtrainingonsuccessfulgrantandmanuscriptpreparation. ?Bring together faculty and fellows through seminar series and other academic activities to create a collaborativecommunityofphysician-scientists. ?Provide guidance for structured learning opportunities on the principles of genetic research, including researchethicsandtheprotectionofanimalandhumansubjects. To achieve these goals, we have designed a program offering mentored independent research with a team approach and scholarship oversight. The program provides career mentorship, including individualized independent development plans (IDP) and workshops focusing on professional development and career advancementskills.Seminarsarefocusedoncuttingedgeresearchandprogressinthefield.Inthefirstcycle of funding, we have trained 6 outstanding fellows, 4 of whom have graduated and are pursuing successful academiccareers,3withadditionalfunding.Ourgoaloverthenext5yearsistobuilduponthisfoundationto continuously improve our training program with innovative opportunities, and continue our mission of training thenextgenerationofphysicianscientiststoinvestigatethecomplexgeneticsofGIdisorders.

Public Health Relevance

Children are affected by a wide variety of diseases that impact the gastrointestinal system. The goal of this program is to train post-MD and -PhD researchers at the Children's Hospital of Philadelphia and the Perelman School of Medicine to successfully pursue careers dedicated to investigating the genetic basis of pediatric gastrointestinal, liver, and nutritional disease, and to use that knowledge to improve the health of children and adults.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK101371-07
Application #
9944525
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
2014-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19146
Fahey, Lisa M; Guzek, Ryan; Ruffner, Melanie A et al. (2018) EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis. Pediatr Allergy Immunol 29:565-568
Fahey, Lisa M; Chandramouleeswaran, Prasanna M; Guan, Shaobo et al. (2018) Food allergen triggers are increased in children with the TSLP risk allele and eosinophilic esophagitis. Clin Transl Gastroenterol 9:139
Estrada, Michelle A; Zhao, Xiao; Lorent, Kristin et al. (2018) Synthesis and Structure-Activity Relationship Study of Biliatresone, a Plant Isoflavonoid That Causes Biliary Atresia. ACS Med Chem Lett 9:61-64
Kim, Dorothy; Hofstaedter, Casey E; Zhao, Chunyu et al. (2017) Optimizing methods and dodging pitfalls in microbiome research. Microbiome 5:52
Conrad, Máire A; Dawany, Noor; Sullivan, Kathleen E et al. (2017) Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 23:2252-2255
Koo, Kyung A; Waisbourd-Zinman, Orith; Wells, Rebecca G et al. (2016) Reactivity of Biliatresone, a Natural Biliary Toxin, with Glutathione, Histamine, and Amino Acids. Chem Res Toxicol 29:142-9
Waisbourd-Zinman, Orith; Koh, Hong; Tsai, Shannon et al. (2016) The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology 64:880-93
Zhao, Xiao; Lorent, Kristin; Wilkins, Benjamin J et al. (2016) Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology 64:894-907
Lorent, Kristin; Gong, Weilong; Koo, Kyung A et al. (2015) Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med 7:286ra67